Early Access — free while we kick the tires
EdgarHawk

Sanchez Juan

Director

Director
1 filing analyzed · 1 company · Latest 2025-11-06

Never miss a filing from Sanchez Juan

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Nuvectis Pharma, Inc. NVCT 1 0 Net buying

Activity

November 2025
2025-11-06 Nuvectis Pharma, Inc. NVCT
high
Buy
13,000 shares
$75,270
Significance 6/10

Director Sanchez Juan purchased 13,000 shares at $5.79; cluster buy pattern with 3 other insiders in past 14 days despite -48.4% from 52-week high.

Sanchez Juan, a Director, acquired 13,000 shares at $5.79 on 2025-11-05, increasing his holdings by 20.0% to 78,150 shares total. This purchase occurs within a broader pattern of insider accumulation: 3 other insiders also bought within the past 14 days. The timing is notable given the stock's current price of $5.67 is -48.4% from its 52-week high of $10.98, placing the transaction near recent lows. However, the company's fundamental position is challenged: it reported negative net income of $-7,462,000.00 over its most recent full fiscal year. The cluster buying pattern combined with significant share accumulation by multiple insiders warrants examination of whether this represents informed confidence in recovery or a coincidental purchasing period amid depressed valuation.

Related insiders